The SPIN - Scleroderma Support Group Leader EDucation Program Trial (SPIN-SSLED) (SPIN-SSLED)
Scleroderma, Systemic
About this trial
This is an interventional supportive care trial for Scleroderma, Systemic focused on measuring Scleroderma, Systemic Sclerosis, Peer Support Group, Training
Eligibility Criteria
Inclusion Criteria:
- Be a current scleroderma support group leader or have been identified by our partner patient organizations as a new leader
- Be available to participate at times when sessions are scheduled
- Be able to use the internet to access the training program
- Be English or French-speaking
Exclusion Criteria:
- Having a co-leader enrolled in trial
Sites / Locations
- Jewish General Hospital
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Training group
Wait-list control group
Participants in the training group will receive a 13-week training program delivered via videoconference. The program includes 13 modules delivered via videoconference over the course of the 3-month program in weekly 60- to 90-minute sessions. Participants will receive a training manual, be shown filmed vignettes, and will have access to a chatroom and an online resource centre.
Participants in the wait-list control group will not receive the training program and will have no access to the resources indicated above.